tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

COGT Stock Latest News

Cogent Biosciences price target raised to $10 from $8 at Baird
The FlyCogent Biosciences price target raised to $10 from $8 at Baird
15d ago
COGT
Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright
PremiumThe Fly
Cogent Biosciences price target lowered to $17 from $19 at H.C. Wainwright
17d ago
COGT
Cogent Biosciences announces trials in patients with GIST completes enrollment
PremiumThe Fly
Cogent Biosciences announces trials in patients with GIST completes enrollment
17d ago
COGT
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
PremiumThe Fly
Cogent Biosciences price target lowered to $20 from $26 at Guggenheim
1M ago
COGT
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
PremiumPress Releases
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results
1M ago
COGT
Cogent Biosciences expects cash to fund operations into 2027
PremiumThe FlyCogent Biosciences expects cash to fund operations into 2027
1M ago
COGT
Cogent Biosciences announces upcoming milestones
Premium
The Fly
Cogent Biosciences announces upcoming milestones
1M ago
COGT
Cogent Biosciences reports Q2 EPS (59c), consensus (56c)
Premium
The Fly
Cogent Biosciences reports Q2 EPS (59c), consensus (56c)
1M ago
COGT
Cogent Biosciences announces FDA meeting, alignment of MS2D2
PremiumThe Fly
Cogent Biosciences announces FDA meeting, alignment of MS2D2
3M ago
COGT
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
PremiumPress Releases
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
3M ago
COGT
Cogent Biosciences announces clinical data from Part 1 of ongoing SUMMIT trial
PremiumThe Fly
Cogent Biosciences announces clinical data from Part 1 of ongoing SUMMIT trial
3M ago
COGT
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
PremiumPress Releases
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer
4M ago
COGT
Cogent Biosciences names Cole Pinnow chief commercial officer
PremiumThe FlyCogent Biosciences names Cole Pinnow chief commercial officer
4M ago
COGT
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting
Premium
Press Releases
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting
4M ago
COGT
3 Best Stocks to Buy Now, 5/8/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 5/8/2024, According to Top Analysts 
4M ago
SGH
COGT
Cogent Biosciences reports Q1 EPS (62c), consensus (52c)
PremiumThe Fly
Cogent Biosciences reports Q1 EPS (62c), consensus (52c)
5M ago
COGT
Cogent Biosciences Reports First Quarter 2024 Financial Results
PremiumPress Releases
Cogent Biosciences Reports First Quarter 2024 Financial Results
5M ago
COGT
Cogent Biosciences presents preclinical data of CNS-penetrant ErbB2 inhibitor
PremiumThe Fly
Cogent Biosciences presents preclinical data of CNS-penetrant ErbB2 inhibitor
5M ago
COGT
Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
PremiumPress Releases
Cogent Biosciences Presents Data Highlighting Potential Best-in-Class Potency and Selectivity of Novel, EGFR Sparing, CNS-Penetrant ErbB2 Inhibitor
5M ago
COGT
Cogent Biosciences files to sell 31.2M shares of common stock for holders
PremiumThe FlyCogent Biosciences files to sell 31.2M shares of common stock for holders
6M ago
COGT
Cogent Biosciences price target raised to $19 from $13 at H.C. Wainwright
Premium
The Fly
Cogent Biosciences price target raised to $19 from $13 at H.C. Wainwright
7M ago
COGT
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Premium
Press Releases
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
7M ago
COGT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >